Trinity profits up almost a quarter in Q3

ISEQ-listed Trinity Biotech has announced a 24.2% profit increase for 2004’s third quarter.

Revenues for Q3 increased 6.9% to $21.4m (€17m) compared to $20.1m (€16m) in Q2.